Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis
Source abstract
Abstract
HNV-loaded PLGA microspheres (HNV-PLGA MSs) were prepared by water-in-oil-in-water (w/o/w) double emulsion solvent evaporation technique. The surface of prepared HNV-PLGA MSs is smooth and nonporous with an average diameter of 69.9 μm. The drug-loading rate and encapsulation rate of HNV-PLGA MSs are 4.40 ± 0.26% and 48.51 ± 14.83%, respectively. Additionally, 43.36% of HNV was released from PLGA MSs after seven days of incubation. The antibacterial effects of HNV released from PLGA were as good as the pure HNV. HNV-loaded PLGA microspheres were successfully prepared using double emulsion solvent evaporation technique and their properties met the requirements for local anti-infection.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Osteomyelitis and Bone Disorders Research · Infectious Diseases and Tuberculosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedic Trauma, Affiliated General Hospital, Ning Xia Medical University, Yinchuan, China;
Hebei Province People's Hospital, Qian'an, China;
Ning Xia Medical University, Yinchuan, China;
State Key Laboratory of New Ceramics and Fine Processing, Department of Materials Science and Engineering, Tsinghua University, Beijing, China
Funding
National Natural Science Foundation of China
References (25)
Show source-provided references
1. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
2. Bao-lin L. · Chinese J Hospital Pharm · 2009 · 2 · 022
3. 10.1016/j.joms.2008.06.02910.1016/j.joms.2008.06.029 ↗
4. Conterno LO · Cochrane Database Syst Rev · 2009 · 8 · CD004439
5. 10.1002/app.3401710.1002/app.34017 ↗
6. 10.1021/bk-1991-046910.1021/bk-1991-0469 ↗
7. 10.3109/21691401.2014.94464610.3109/21691401.2014.944646 ↗
8. 10.1016/j.ejpb.2003.10.01810.1016/j.ejpb.2003.10.018 ↗
9. 10.1016/S0168-3659(98)00165-510.1016/S0168-3659(98)00165-5 ↗
10. 10.1016/0168-3659(93)90190-G10.1016/0168-3659(93)90190-G ↗
11. 10.1016/S0142-9612(00)00115-010.1016/S0142-9612(00)00115-0 ↗
12. 10.1007/s10439-009-9888-610.1007/s10439-009-9888-6 ↗
13. 10.1001/jama.298.15.176310.1001/jama.298.15.1763 ↗
14. 10.3390/polym303137710.3390/polym3031377 ↗
15. 10.1016/j.mib.2012.08.00310.1016/j.mib.2012.08.003 ↗
16. National Committee for Clinical Laboratory Standards (NCCLS). 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Fifth edition. Available from:
17. 10.5372/1905-7415.0504.06710.5372/1905-7415.0504.067 ↗
18. 10.1016/j.injury.2005.10.00810.1016/j.injury.2005.10.008 ↗
19. 10.1002/app.1338510.1002/app.13385 ↗
20. Simamora P · J Drugs Dermatol · 2006 · 5 · 436
21. 10.3109/21691401.2014.95510810.3109/21691401.2014.955108 ↗
22. 10.1111/j.1525-1470.2009.00984.x10.1111/j.1525-1470.2009.00984.x ↗
23. 10.1080/00016470031736228010.1080/000164700317362280 ↗
24. 10.1007/BF0293158010.1007/BF02931580 ↗
25. 10.1016/j.polymdegradstab.2010.10.01010.1016/j.polymdegradstab.2010.10.010 ↗